Holocene Advisors, LP Dexcom Inc Transaction History

Holocene Advisors, LP

$22.9 Billion
Q3 2024

A detailed history of Holocene Advisors, LP transactions in Dexcom Inc stock. As of the latest transaction made, Holocene Advisors, LP holds 29,553 shares of DXCM stock, worth $2.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

29,553

Previous 1,773,235 98.33%

Holding current value

$2.21 Million

Previous $201 Million 99.02%

% of portfolio

0.01%

Previous 0.89%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $112 Million - $202 Million	-1,743,682 Reduced 98.33%	29,553 $1.98 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $15.1 Million - $19.3 Million	137,111 Added 8.38%	1,773,235 $201 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $4.2 Million - $5.15 Million	-36,790 Reduced 2.2%	1,636,124 $227 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $68.9 Million - $113 Million	-912,983 Reduced 35.31%	1,672,914 $208 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $84.5 Million - $135 Million	981,344 Added 61.16%	2,585,897 $241 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $10.5 Million - $12.2 Million	93,377 Added 6.18%	1,604,553 $206 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $12.8 Million - $15.1 Million	122,778 Added 8.84%	1,511,176 $176 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $29.2 Million - $42.2 Million	-343,669 Reduced 19.84%	1,388,398 $157 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $11.6 Million - $14.3 Million	-151,399 Reduced 8.04%	1,732,067 $140 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $99.1 Million - $194 Million	1,457,522 Added 342.19%	1,883,466 $140 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $19.5 Million - $26.9 Million	206,952 Added 94.5%	425,944 $218 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $4.13 Million - $5.17 Million	31,763 Added 16.96%	218,992 $118 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $15.2 Million - $20.4 Million	-142,718 Reduced 43.25%	187,229 $102 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $4.09 Million - $5.45 Million	-50,516 Reduced 13.28%	329,947 $141 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $15.9 Million - $19.6 Million	187,571 Added 97.24%	380,463 $137 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $12.4 Million - $16.7 Million	159,437 Added 476.57%	192,892 $71.3 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $1.44 Million - $1.7 Million	-15,077 Reduced 31.07%	33,455 $13.8 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $15.7 Million - $26.3 Million	-249,912 Reduced 83.74%	48,532 $19.7 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $8.12 Million - $12.8 Million	169,867 Added 132.11%	298,444 $80.4 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $4.53 Million - $7.09 Million	-123,729 Reduced 49.04%	128,577 $28.1 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $8.96 Million - $11.1 Million	252,306 New	252,306 $37.7 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $81,350 - $116,970	-4,638 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $160,494 - $227,838	-12,289 Reduced 72.6%	4,638 $344,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $188,228 - $260,337	16,927	16,927 $971,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

349M

Call Options Held

5.66M

Put Options Held

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Dexcom Inc Transaction History